Vaccination may combat Clostridium difficile

UK - Whilst the life-threatening Clostridium difficile is not absolutely resistant to antibiotics, after an individual has been infected the bacteria often reappears.

Photo: Vaccination may combat Clostridium difficile

Vaccination against it is therefore seen as the possible answer, and now results from initial trials of one made by Acambis, a Cambridge-based biotech company, have encouraged its scientists to discuss involvement of the National Health Service (NHS) in tests in hospitals this year.
Rather than targeting the infection, this developing vaccine focuses on the toxins produced by a C. difficile infection. Trials on 200 patients indicate that the vaccine was effective at combating one of the major toxins in 100% of cases and a second major toxin in 75% of cases.
It is hoped that a course of three injections will provide long-lasting protection for over a decade.

01.03.2008

More on the subject:

Related articles

Photo

News • Healthcare-associated infections and antimicrobial use

HAI: study reveals serious gaps in infection prevention and control

Healthcare-associated infections (HAI) are a threat to residents of long-term care facilities in Europe. A new study points to serious gaps in infection prevention and control measures.

Photo

Sponsored • Endoscopy disinfection system • MKHYG-5037EN-EMEA

Extensive testing demonstrates the efficiency of the Pentax Medical PlasmaTyphoon™+

Patient safety is at the heart of every medical advancement, and technologies like endoscopes have been pivotal in transforming surgery by enabling minimally invasive procedures. This evolution has…

Photo

News • Infection control

Study highlights transmission risk of resistant bacteria in hospital sinks

A new study identifies hospital sinks as a source of bacterial outbreaks, highlighting the vulnerability for contamination. The researchers also point out the difficulties in stopping such outbreaks.

Related products

Subscribe to Newsletter